Emerging Roles of Nanocarrier in Cancer Therapy
1st Edition
Published on 5. September 2024
194 pages
978-1-040-10599-3 (ISBN)
Description
This book addresses the limitations of existing therapeutic approaches using nanoparticles. Emerging Roles of Nanocarriers in Cancer Therapy will further provide information for the development of successful cancer nanomedicine therapies.
Features
Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment.
Covers in detail the characteristics of various nanotechnology-based drug delivery systems.
Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction.
Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research.
Highlights smart strategies for improving the clinical impact of cancer nanomedicine.
The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.
Features
Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment.
Covers in detail the characteristics of various nanotechnology-based drug delivery systems.
Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction.
Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research.
Highlights smart strategies for improving the clinical impact of cancer nanomedicine.
The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.
More details
Edition
1. Auflage
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Illustrations
1 Tables, black and white; 33 Line drawings, color; 33 Illustrations, color
ISBN-13
978-1-040-10599-3 (9781040105993)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Rishabha Malviya | Arun Kumar Singh | Sonali Sundram
Emerging Roles of Nanocarrier in Cancer Therapy
Book
09/2024
1st Edition
CRC Press
€175.60
Shipment within 10-20 days
Persons
Dr Rishabha Malviya completed B. Pharmacy from Uttar Pradesh Technical University and M. Pharmacy (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh. His PhD (Pharmacy) work was in the area of Novel formulation development techniques. He has more than 12.5 years of research experience and presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University since past 8 years. His area of interest includes formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients.
Arun Kumar Singh completed his B Pharm and M Pharm from Galgotias University India.
Prof Sonali Sundram completed B. Pharm & M. Pharm (Pharmacology) from AKTU, Lucknow. She has worked as research scientist in project of ICMR in King George's Medical University, Lucknow after that she has joined BBDNIIT and currently she is working in Galgotias University, Greater Noida, India. Her PhD (Pharmacy) work was in the area of Neurodegeneration and Nanoformulation. Her area of interest is neurodegeneration, clinical research, artificial intelligence.
Arun Kumar Singh completed his B Pharm and M Pharm from Galgotias University India.
Prof Sonali Sundram completed B. Pharm & M. Pharm (Pharmacology) from AKTU, Lucknow. She has worked as research scientist in project of ICMR in King George's Medical University, Lucknow after that she has joined BBDNIIT and currently she is working in Galgotias University, Greater Noida, India. Her PhD (Pharmacy) work was in the area of Neurodegeneration and Nanoformulation. Her area of interest is neurodegeneration, clinical research, artificial intelligence.
Content
Chapter 1: Nanomedicine as Cancer Therapeutics: Current Trends and Opportunities
Chapter 2: Technology Utilizing Nanoparticles in Treating Cancer
Chapter 3: Targeted Therapy for Cancer with Nanomedicine
Chapter 4: Effective Nanomedicine for cancer Therapy
Chapter 5: Enhancing Cancer Immunotherapy using Nanoparticle-Based Smart Carriers
Chapter 6: Opportunities and Challenges for Anticancer Nanomedicines based on Polymer-Drug Conjugates in Concurrent /combination treatment
Chapter 7: siRNA Therapeutic Nanocarriers for the Treatment of Cancer
Chapter 8: Boosting Nano Medicine Efficacy with Hyperbaric Oxygen Therapy
Chapter 9: Combo Nanomedicine: The Co-delivery of Multimodal Therapies for Effective, Targeted Plus Secure Treatment of Cancer
Chapter 10: Multipurpose Micellar Nanomedicine for the Treatment of Cancer
Chapter 11: Cellular Targeting using Nanoparticles for Targeted Cancer Therapy
Index
Chapter 2: Technology Utilizing Nanoparticles in Treating Cancer
Chapter 3: Targeted Therapy for Cancer with Nanomedicine
Chapter 4: Effective Nanomedicine for cancer Therapy
Chapter 5: Enhancing Cancer Immunotherapy using Nanoparticle-Based Smart Carriers
Chapter 6: Opportunities and Challenges for Anticancer Nanomedicines based on Polymer-Drug Conjugates in Concurrent /combination treatment
Chapter 7: siRNA Therapeutic Nanocarriers for the Treatment of Cancer
Chapter 8: Boosting Nano Medicine Efficacy with Hyperbaric Oxygen Therapy
Chapter 9: Combo Nanomedicine: The Co-delivery of Multimodal Therapies for Effective, Targeted Plus Secure Treatment of Cancer
Chapter 10: Multipurpose Micellar Nanomedicine for the Treatment of Cancer
Chapter 11: Cellular Targeting using Nanoparticles for Targeted Cancer Therapy
Index
